CD33 and acute myeloid leukemia: To determine rapamycin concentration thresholds required for DARIC-VHH T cell activation, we assayed cytokine release from 24-hour cocultures of DARIC-VHH T cells and CD33+ AML target cells, including a rapamycin concentration range up to 4 nM (Figure 2A).